In Systemic Medicine, severe ocular allergies and Vernal Keratoconjunctivitis (VKC) are not seen only as local problems to be controlled with eye drops, but also as expressions of increased immune reactivity at mucosal surfaces. The clinical aim is to complement essential ophthalmic therapies with a broader assessment of the patient's inflammatory and systemic "terrain", without replacing guideline‑based treatments.

⚠️ Itching, Eye‑Rubbing and Corneal Risk

In Vernal Keratoconjunctivitis (VKC), itching can be intense and lead children and adolescents to rub their eyes repeatedly and vigorously (eye‑rubbing). Over time, this behavior is a significant risk factor for corneal shape alterations, including progression towards keratoconus. Adequate control of allergic symptoms and clear education for patients and families about avoiding eye‑rubbing are crucial to protect corneal integrity.

Hover over the cards to see, in a simplified way, which factors may amplify the allergic response or help modulate it. This scheme is for educational purposes only.

Th2‑Skewed Immune Profile

Reduced tolerance to allergens. In some individuals the immune system shifts towards a Th2‑dominant response, with increased IgE production against common allergens (such as pollen). Conjunctival mast cells thus become more reactive, predisposing to episodes of itching, redness and tearing.

Dysbiotic Setting

Gut–mucosa axis. Alterations in the intestinal microbiota and increased gut permeability have been proposed as contributing factors in modulating systemic immune responses. Within this framework, the gut–eye axis is considered one of the elements potentially influencing mucosal allergic susceptibility.

Histamine Load

Summation of stimuli. Histamine can arise from local mast cell degranulation, from diet (histamine‑rich or histamine‑releasing foods) and from bacterial metabolism. When overall histamine load is high, even relatively modest allergen exposure may be perceived more intensely by sensitized patients.

Microbiota Support

Modulating the terrain. Targeted interventions on diet and gut microbiota (including selected probiotics when indicated) are being studied for their potential to improve mucosal immune regulation. These strategies should be viewed as supportive measures integrated into an individualized, physician‑guided treatment plan.

Vitamin D and Immune Balance

Vitamin D3 is recognized as an immune‑modulating hormone, and documented deficiency may warrant correction as part of comprehensive patient management, under medical supervision. In selected cases, a time‑limited low‑histamine diet may also be considered, always on specialist advice.

Phytonutraceuticals (e.g. Quercetin)

Natural flavonoids such as Quercetin have been investigated for their potential to stabilize mast cells and modulate the release of inflammatory mediators. Their use should be considered as an adjunct, not a replacement for prescribed medications (antihistamines, corticosteroids, immunomodulators), and always tailored in agreement with the treating physician.

Selected Scientific References

Leonardi A. Vernal keratoconjunctivitis: pathogenesis and clinical findings. Progress in Retinal and Eye Research, 2002.
Katelaris CH, et al. Ocular allergy: implications for the clinical immunologist. Annals of Allergy, Asthma & Immunology, 2003.
Zaalberg A, et al. The role of the microbiome in ocular surface disease. Current Opinion in Allergy and Clinical Immunology, 2021.
Weng Z, et al. Quercetin, a bioflavonoid, inhibits the release of pro-inflammatory mediators from human mast cells. European Journal of Pharmacology, 2012.

Clinical Management of Ocular Allergies

Integrated diagnostic assessment to protect the ocular surface and cornea.

info: medicioculisti.it

Medical and Ethical Disclaimer

The contents of this page are intended strictly for educational and informational purposes. Considerations regarding microbiota, nutrition, Vitamin D and phytonutraceuticals may provide supportive measures but do not in any way replace an ophthalmological examination, specialist diagnosis or established treatment protocols for ocular allergy and Vernal Keratoconjunctivitis (VKC). Any change in therapy, introduction of supplements or dietary modification must be discussed and agreed upon with your eye specialist and, when appropriate, your pediatrician or general physician. In case of ocular pain, visual loss, marked photophobia or rapid worsening of symptoms, urgent ophthalmologic evaluation is required.